Status:

COMPLETED

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

Lead Sponsor:

University of Alberta

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

PHASE2

Brief Summary

Single centre prospective cohort phase II study of 18F-PSMA-1007 PET/CT imaging in patients with biochemically recurrent or high-risk prostate cancer. Safety, biodistribution, clinical efficacy, and d...

Detailed Description

A single centre prospective cohort phase II study of 18F-PSMA-1007 PET/CT imaging in specific patient populations: 1. Adult patients (≥ 18 years old) with a history of radical prostatectomy for treat...

Eligibility Criteria

Inclusion

  • Adult patients (≥ 18 years old) with a history of radical prostatectomy for treatment of prostate cancer, and a serum prostate specific antigen (PSA) \> 0.2 µg/L
  • Adult patients (≥ 18 years old) with a history of radiotherapy, cryotherapy, or brachytherapy for treatment of prostate cancer, and a serum PSA progressively rising to ≥ 2 µg/L (minimum two samples) OR a serum PSA doubling-time of \< 9 months
  • Adult patients (≥ 18 years old) with a history of biopsy-proven prostate cancer and high-risk features for metastatic disease prior to treatment with radical prostatectomy, radiotherapy, cryotherapy, or brachytherapy. High-risk features include a Gleason score \> 7, serum PSA \> 20 µg/L, OR minimum clinical T-stage T2c.

Exclusion

  • Unable to obtain consent
  • Weight \>225 kg (weight limitation of PET/CT scanner)
  • Unable to lie flat for 30 minutes to complete the PET-CT imaging session
  • Lack of intravenous access
  • Both CT scan of the chest, abdomen, and pelvis and 99mTc-MDP bone scan within 3 months
  • History of allergic reaction to 18F-PSMA-1007 or 99mTc-MDP

Key Trial Info

Start Date :

August 31 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 9 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04733768

Start Date

August 31 2021

End Date

August 9 2022

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Alberta

Edmonton, Alberta, Canada, T6G 2B7